The University of Miami, through its Office of Research Administration - School of Medicine Division, was awarded a $894,330 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 2-year research project to investigate "Targeting Axonal Regeneration Pathways as a Therapeutic Approach to ALS", with a performance period from February 1, 2025 to January 31, 2027. The university's specialized expertise in biomedical research and experience as a prime recipient of federal grants will be leveraged to conduct innovative scientific studies aimed at developing new treatment approaches for amyotrophic lateral sclerosis (ALS). This federal grant supports the program's objective of transforming healthcare for military service members and the public through impactful medical research across a range of disciplines.
Generated 3/4/25, 7:22 AM